OmniAb (OABI) Asset Utilization Ratio (2022 - 2026)
OmniAb (OABI) reported Asset Utilization Ratio of 0.1 for Q1 2026, up 14.97% year-over-year from 0.08 in Q1 2025, and up 59.22% quarter-over-quarter from 0.06 in Q4 2025.
OmniAb (OABI) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Asset Utilization Ratio data on file, last reported at 0.1 in Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.1, up 14.97% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.1 (up 14.97% YoY), and the FY2025 annual result was 0.06, down 20.88% from the prior year.
- Asset Utilization Ratio advanced to 0.1 in Q1 2026 per OABI's latest filing, from 0.06 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.18 in Q4 2022 and troughed at 0.06 in Q1 2024.
- A 5-year average of 0.1 and a median of 0.08 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio sank 63.65% in 2024, then soared 46.39% in 2025.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.18 in 2022, then tumbled by 50.3% to 0.09 in 2023, then declined by 9.84% to 0.08 in 2024, then dropped by 23.88% to 0.06 in 2025, then jumped by 59.22% to 0.1 in 2026.
- Business Quant data shows OABI's Asset Utilization Ratio at 0.1 in Q1 2026, 0.06 in Q4 2025, and 0.07 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.10 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 0.08 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.08 |
| Sep 30, 2024 | 0.06 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.09 |
| Sep 30, 2023 | 0.16 |
| Jun 30, 2023 | 0.16 |
| Mar 31, 2023 | 0.16 |
| Dec 31, 2022 | 0.18 |